| Literature DB >> 25491157 |
Neil Johns1, Russell W Jamieson2, Carlo Ceresa3, Carl Moores4, Alastair F Nimmo5, Orwa Falah6, Paul J Burns7, Roderick T A Chalmers8.
Abstract
BACKGROUND: Endovascular technology now permits total endovascular thoracoabdominal aortic aneurysm (TAAA) repair with high volume centres reporting encouraging results. The long-term durability of such stent grafts is unknown, leading to concerns regarding their use in younger patients. This study reports contemporary outcomes of open repair in young patients.Entities:
Mesh:
Year: 2014 PMID: 25491157 PMCID: PMC4269840 DOI: 10.1186/s13019-014-0195-4
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Patient demographics
| No of patients (n = 37) | |
|---|---|
| Age (years)* | 56 (22–60) |
| Sex ratio (M : F) | 31 : 6 |
| Cardiac disease | 12 (32) |
| Ischaemic heart disease | 11 (30) |
| Arrhythmia | 1 (3) |
| Respiratory disease | 6 (15) |
| COPD | 6 (15) |
| Renal Disease | 5 (19) |
| Biochemical evidence of dysfunction | 5 (19) |
| Diabetes mellitus | 1 (3) |
| Smoking history | 31 (84) |
| Current smoker | 16 |
| Ex smoker | 15 |
| ASA physical status* | 3 (2–4) |
| Type of aneurysm | |
| I | 3 (8) |
| II | 10 (27) |
| III | 7 (19) |
| IV | 17 (46) |
| Aneurysm diameter (cm)* | 6.9 (5.6 -11.0) |
| Pathology | |
| Chronic dissection | 10 (27) |
| Degeneration without dissection | 18 (49) |
| Connective tissue disease | 7 (19) |
| Mycotic | 2 (5) |
Values in parentheses are percentages unless indicated otherwise; *values are median (range). COPD, chronic obstructive pulmonary disease; ASA, American Society of Anesthesiologists.
Figure 1A CT reconstruction of a type II TAAA.
Figure 2A complete replacement of the thoracic aorta and 2 jump grafts coming off to revascularise the intercostals arteries. The L lung is deflated, the LHB cannula is in place.
Figure 3Flow diagram showing distribution of patients undergoing TAAA repair between 2001 – 2013.
Patient outcomes
| Crawford type repair | |||
|---|---|---|---|
| I, II, III | IV | All | |
|
| |||
| MI/Troponin rise | 2 (10) | 1 (6) | 3 (8) |
| Arrhythmia | 5 (25) | 2 (12) | 7 (19) |
| Cardiac arrest | 0 (0) | 0 (0) | 0 (0) |
|
| |||
| Pneumonia | 6 (30) | 7 (41) | 13 (35) |
| Adult respiratory distress syndrome | 1 (5) | 1 (6) | 2 (5) |
| Effusion requiring drainage | 3 (15) | 0 (0) | 3 (8) |
| Reintubation | 3 (15) | 1 (6) | 4 (11) |
|
| |||
| Creatinine >150% of baseline | 5 (25) | 5 (29) | 10 (27) |
| Renal replacement therapy | 1 (5) | 3 (18) | 4 (11) |
|
| |||
| Temporary paraplegia | 3 (15) | 0 (0) | 3 (8) |
| Permanent paraplegia | 0 (0) | 0 (0) | 0 (0) |
|
| 1 (5) | 0 (0) | 1 (3) |
|
| 2 (10) | 0 (0) | 2 (5) |
Values in parentheses are percentages unless indicated otherwise.
Figure 4Kaplan Meier survival plot of patients undergoing TAAA repair between 2001 – 2013. The mean (SEM) survival time was 138.5 (11) months. The 5 year survival was 79.7% (8.3).